CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.07.032
Abstract: This study examined the protective efficacy of and immune response to a nasal influenza vaccine combined with a novel mucosal oligodeoxynucleotide (ODN) adjuvant, CpG ODN G9.1 (G9.1), in a model of infection limited to the… read more here.
Keywords: infection limited; influenza virus; protection; infection ... See more keywords
Mycobacterium Abscessus Infection Limited to the Main Bronchus
Sign Up to like & getrecommendations! Published in 2020 at "Internal Medicine"
DOI: 10.2169/internalmedicine.4883-20
Abstract: A 68-year-old woman presented to the hospital with a 2month history of chronic cough. She had no complications and was not immunocompromised. Computed tomography (CT) revealed only thickening of the left main bronchus (Picture A).… read more here.
Keywords: main bronchus; abscessus; infection limited; abscessus infection ... See more keywords